Title : The irreversible ERBB1/2/4 inhibitor neratinib interacts with the BCL-2 inhibitor venetoclax to kill mammary cancer cells.

Pub. Date : 2018 Mar 4

PMID : 29333953






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The irreversible ERBB1/2/4 inhibitor neratinib interacts with the BCL-2 inhibitor venetoclax to kill mammary cancer cells. neratinib epidermal growth factor receptor Homo sapiens
2 The irreversible ERBB1/2/4 inhibitor, neratinib, down-regulates the expression of ERBB1/2/4 as well as the levels of MCL-1 and BCL-XL. neratinib epidermal growth factor receptor Homo sapiens
3 The irreversible ERBB1/2/4 inhibitor, neratinib, down-regulates the expression of ERBB1/2/4 as well as the levels of MCL-1 and BCL-XL. neratinib epidermal growth factor receptor Homo sapiens